8,093 Shares in Encompass Health Co. (NYSE:EHC) Bought by Hancock Whitney Corp

Hancock Whitney Corp acquired a new stake in Encompass Health Co. (NYSE:EHC) in the third quarter, Holdings Channel reports. The fund acquired 8,093 shares of the company’s stock, valued at approximately $782,000.

Several other hedge funds have also bought and sold shares of EHC. Centaurus Financial Inc. bought a new stake in Encompass Health during the 3rd quarter worth approximately $108,000. Algert Global LLC boosted its holdings in Encompass Health by 89.5% during the 3rd quarter. Algert Global LLC now owns 150,570 shares of the company’s stock worth $14,551,000 after acquiring an additional 71,132 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Encompass Health in the 3rd quarter worth $1,778,000. Commerce Bank raised its holdings in shares of Encompass Health by 2.6% in the third quarter. Commerce Bank now owns 7,835 shares of the company’s stock valued at $757,000 after purchasing an additional 200 shares during the last quarter. Finally, Segall Bryant & Hamill LLC lifted its position in shares of Encompass Health by 12.6% during the third quarter. Segall Bryant & Hamill LLC now owns 160,137 shares of the company’s stock valued at $15,476,000 after purchasing an additional 17,902 shares in the last quarter. Institutional investors and hedge funds own 97.25% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently issued reports on EHC. Truist Financial reaffirmed a “buy” rating and issued a $116.00 target price (up from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Stephens restated an “overweight” rating and issued a $105.00 price objective on shares of Encompass Health in a research note on Tuesday, August 6th. Barclays lifted their target price on Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 29th. UBS Group increased their price target on shares of Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a research report on Wednesday, September 25th. Finally, KeyCorp lifted their price objective on shares of Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. Nine equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, Encompass Health presently has an average rating of “Buy” and an average price target of $107.11.

Encompass Health Stock Performance

NYSE:EHC opened at $103.77 on Wednesday. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04. The firm has a market cap of $10.45 billion, a price-to-earnings ratio of 25.06, a PEG ratio of 1.34 and a beta of 0.88. Encompass Health Co. has a 52-week low of $63.78 and a 52-week high of $104.55. The business’s fifty day moving average is $97.28 and its 200 day moving average is $90.99.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, topping the consensus estimate of $0.94 by $0.09. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The firm had revenue of $1.35 billion for the quarter, compared to analysts’ expectations of $1.33 billion. During the same quarter in the prior year, the firm posted $0.86 earnings per share. The business’s quarterly revenue was up 11.9% on a year-over-year basis. Research analysts predict that Encompass Health Co. will post 4.29 EPS for the current year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be given a $0.17 dividend. The ex-dividend date is Thursday, January 2nd. This represents a $0.68 dividend on an annualized basis and a yield of 0.66%. Encompass Health’s payout ratio is 16.43%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.